The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling
复制标题
DOI：
10.1007/s40258-015-0200-7
复制
发表时间：
2016-04-01
影响因子：
3.6
通讯作者：
Feenstra, Talitha L.
中科院分区：
文献类型：
--
作者：
van Voorn, George A. K.;Vemer, Pepijn;Feenstra, Talitha L.
对医疗保健干预措施的评估，例如新药或其他新的治疗策略，通常包括基于健康经济（HE）模型应用的成本效益分析（CEA）。作为最终用户，患者是关于CEA结果的重要利益相关者，但他们对HE模型开发和应用的了解或参与其中的情况并不存在。本文考虑了患者参与HE模型开发和应用对建模者和患者的可能益处和风险。在各个学科的参与建模的知识产权的文献进行了探索性的审查。此外，荷兰患者专家接受了采访，了解他们在应用HE模型方面的经验和意见。患者对HE模型知之甚少或一无所知，很少参与HE模型开发，并且已对各学科中涉及患者的建模进行了文献探索性综述。此外，荷兰患者专家接受了采访，了解他们在应用HE模型方面的经验和意见。患者对HE模型知之甚少，很少参与HE模型的开发和应用。
Evaluations of healthcare interventions, e.g. new drugs or other new treatment strategies, commonly include a cost-effectiveness analysis (CEA) that is based on the application of health economic (HE) models. As end users, patients are important stakeholders regarding the outcomes of CEAs, yet their knowledge of HE model development and application, or their involvement therein, is absent. This paper considers possible benefits and risks of patient involvement in HE model development and application for modellers and patients. An exploratory review of the literature has been performed on stakeholder-involved modelling in various disciplines. In addition, Dutch patient experts have been interviewed about their experience in, and opinion about, the application of HE models. Patients have little to no knowledge of HE models and are seldom involved in HE model development and exploratory review of the literature has been performed on stakeholder-involved modelling in various disciplines. In addition, Dutch patient experts have been interviewed about their experience in, and opinion about, the application of HE models. Patients have little to no knowledge of HE models and are seldom involved in HE model development and application.